PGD

Approximately 85-90% of repeated pregnancy loss is due to genetic problems. This is a difficult and frustrating experience. However, there are solutions and treatment options that will help you, including IHR’s Preimplantation Genetic Diagnosis (PGD) treatment program. We offer PGD at RGI's Institute for Human Reproduction using the nation’s leading genetic laboratory.

Treatment:

PGD involves the genetic investigation of early stage embryos, which have been produced through in-vitro fertilization (IVF). PGD allows us to determine the sex of any given embryo (female or male) and the chromosomal make-up ( whether the embryo is chromosomally normal, or, for example, has Down’s syndrome). In more complicated testing procedures, it is possible to find out if embryos are affected by such diseases as Tay-Sachs disease, Cystic Fibrosis, Sickle Cell disease, Huntington’s Chorea disease, Cooley’s Anemia, as well as many other genetically inherited diseases (See the complete list). PGD is also used in non-medically related gender selection. In contrast to other available gender selection techniques, which are largely based on sperm sorting (X- vs. Y-carrying sperm), PGD is virtually always accurate.

PGD Value:

Your infertility specialist will determine if PGD is the correct treatment plan for you. PGD offers:

• Reduce risk of miscarriage
• Improvement in pregnancy success rate
• Reduce risk of genetic disorders
• Ability for gender selection (if qualified)

Next Steps:

If you are interested in PGD your next step should be:

• Check out our FAQs
• Obtain a Free e-Mail Consultation
• Arrange a Telephone Consultation